Newsletter vom 01.06.2023 | Zuletzt geändert am 19.06.2023
UBA aktuell - Nr.: 3/2023
… existing problems related to data gaps, non-harmonized assessments, insufficient post-market control, and data transparency of pharmaceuticals, and identifies …
